Outcomes in rheumatoid arthritis patients undergoing total joint arthroplasty

International Journal of Clinical Rheumatology

Volumn 9, Issue 6, 2014, Pages 585-593

  Goodman, Susan M ^a   Ravi, Bheeshma ^b   Hawker, Gillian ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

CEREBROVASCULAR ACCIDENT; COMORBIDITY; COMPARATIVE STUDY; DEATH; DEEP VEIN THROMBOSIS; DISEASE REGISTRY; DISLOCATION; FUNCTIONAL STATUS; HEALTH CARE COST; HEART INFARCTION; HIP ARTHROPLASTY; HUMAN; INCIDENCE; JOINT FUNCTION; LUNG DISEASE; LUNG EMBOLISM; OSTEOARTHRITIS; POSTOPERATIVE INFECTION; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEPSIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

EID: 84919785814     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.14.47     Document Type: Review

References (115)

1. Pincus T, Sokka TF, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum. 52(4), 1009-1019 (2005).
2. Pincus T, Sokka TF, Chung CP, Cawkwell G. Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials. Ann. Rheum. Dis. 65(7), 878-883 (2006).
3. Weinblatt ME, Kremer JM, Bankhurst AD et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340(4), 253-259 (1999).
4. van der Heijde D, Klareskog LF, Rodriguez-Valverde VF et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum. 54(4), 1063-1074 (2006).
5. Emery P, Breedveld FC, Hall S et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372(9636), 375-382 (2008).
6. Keystone EC, Kavanaugh AF, Sharp JT et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum. 50(5), 1400-1411 (2004).
7. Welsing PM, Fransen JF, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum. 52(9), 2616-2624 (2005).
8. Uhlig T, Heiberg TF, Mowinckel PF, Kvien TK. Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann. Rheum. Dis. 67(12), 1710-1715 (2008).
9. Kapetanovic MC, Lindqvist E, Saxne TF, Eberhardt K. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann. Rheum. Dis. 67(10), 1412-1416 (2008).
10. Massardo L, Gabriel SE, Crowson CS, O'Fallon WM, Matteson EL. A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis. J. Rheumatol. 29(1), 52-56 (2002).
11. Weiss RJ, Stark AF, Wick MC, Ehlin AF, Palmblad KF, Wretenberg P. Orthopaedic surgery of the lower limbs in 49,802 rheumatoid arthritis patients: results from the Swedish National Inpatient Registry during 1987 to 2001. Ann. Rheum. Dis. 65(3), 335-341 (2006).
12. Hekmat K, Jacobsson LF, Nilsson JA et al. Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden. Arthritis Res. Ther. 13(2), R67 (2011).
13. Skytta ET, Honkanen PB, Eskelinen AF, Huhtala HF, Remes V. Fewer and older patients with rheumatoid arthritis need total knee replacement. Scand. J. Rheumatol. 41(5), 345-349 (2012).
14. Shourt CA, Crowson CS, Gabriel SE, Matteson EL. Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality. J. Rheumatol. 39(3), 481-485 (2012).
15. Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman SM, Figgie MP, Mandl LA. US trends in rates of arthroplasty for inflammatory arthritis including rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis. Arthritis Rheumatol. 66(6), 1432-1439 (2014).
16. Mont MA, Jacobs JJ. AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J. Am. Acad. Orthop. Surg. 19(12), 777-778 (2011).
17. Sokka T, Kautiainen HF, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann. Rheum. Dis. 66(3), 341-344 (2007).
18. Quam JP, Michet CJ Jr, Wilson MG et al. Total knee arthroplasty: a population-based study. Mayo Clin. Proc. 66(6), 589-595 (1991).
19. Katz JN, Losina E, Barrett J et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J. Bone Joint Surg. Am. 83(11), 1622-1699 (2001).
20. Stundner O, Chiu YL, Sun XF et al. Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study. Clin. Exp. Rheumatol. 31(6), 889-895 (2013).
21. Stundner O, Danninger T, Chiu YL et al. Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes. J. Arthroplasty 29(2), 308-313 (2014).
22. Paterson JM, Williams JI, Kreder HJ et al. Provider volumes and early outcomes of primary total joint replacement in Ontario. Can J. Surg. 53(3), 175-183 (2010).
23. Ravi B, Croxford R, Reichmann WM, Losina E, Katz JN, Hawker GA. The changing demographics of total joint arthroplasty recipients in the United States and Ontario from 2001 to 2007. Best Pract. Res. Clin. Rheumatol. 26(5), 637-647 (2012).
24. Jennings F, Lambert E, Fredericson M. Rheumatic diseases presenting as sports-related injuries. Sports Med. 38, 917-930 (2008).
25. Hurkmans E, van der Giesen FJ, Vliet Vlieland TP et al. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with RA. Cochrane Database Syst. Rev.. 4, CD006853 (2009).
26. Business Wire: Baby boomers expect to beat the odds with more active, longer lives. www.businesswire.com/news/home/20031223005029/en/Baby-Boomers-Expect-Beat-Odds-Active-Longer
27. Shervin N, Rubash HE, Katz JN. Orthopaedic procedure volume and patient outcomes: a systematic literature review. Clin. Orthop. Relat. Res. 457, 35-41 (2007).
28. Soohoo NF, Farng E, Lieberman JR, Chambers LF, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin. Orthop. Relat. Res. 468(9), 2363-2371 (2010).
29. Ravi B, Escott B, Shah PS et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 64(12), 3839-3849 (2010).
30. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 96(5), 1140-1146 (2002).
31. Kim SC, Schneeweiss S, Liu JF, Solomon DH. Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res. (Hoboken) 65(10), 1600-1607 (2013).
32. Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum. 64(1), 53-61 (2012).
33. Holmqvist ME, Neovius MF, Eriksson JF et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 308(13), 1350-1356 (2012).
34. Fleisher LA, Beckman JA, Brown KA et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 120(21), e169-e276 (2009).
35. Urban MK, Jules-Elysee KF, Loughlin CF, Kelsey WF, Flynn E. The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J. 4(1), 76-80 (2008).
36. Basilico FC, Sweeney GF, Losina E et al. Risk factors for cardiovascular complications following total joint replacement surgery. Arthritis Rheum. 58(7), 1915-1920 (2008).
37. Avina-Zubieta JA, Choi HK, Sadatsafavi MF, Etminan MF, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 59(12), 1690-1697 (2008).
38. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol. 33(11), 2167-2172 (2006).
39. Shoenfeld Y, Gerli RF, Doria AF et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112(21), 3337-3347 (2005).
40. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am. J. Med. 121(10 Suppl. 1), S3-S8 (2008).
41. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am. J. Med. 121(10 Suppl. 1), S9-S14 (2008).
42. Solomon DH, Kremer JF, Curtis JR et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann. Rheum. Dis. 69(11), 1920-1925 (2010).
43. Provan SA, Semb AG, Hisdal JF et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann. Rheum. Dis. 70(5), 812-817 (2011).
44. Lindhardsen J, Ahlehoff OF, Gislason GH et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann. Rheum. Dis. 70(6), 929-934 (2011).
45. Yazdanyar A, Wasko MC, Kraemer KL, Ward MM. Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum. 64(8), 2429-2437 (2012).
46. Innala L, Moller BF, Ljung LF et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res. Ther. 13(4), R131 (2011).
47. Kurtz S, Ong KF, Lau E, Mowat FF, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 89(4), 780-785 (2007).
48. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 46(9), 2287-2293 (2002).
49. Schrama JC, Espehaug BF, Hallan GF et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res. (Hoboken) 62(4), 473-479 (2010).
50. Jamsen E, Varonen MF, Huhtala HF et al. Incidence of prosthetic joint infections after primary knee arthroplasty. J. Arthroplasty 25(1), 87-92 (2010).
51. Bongartz T, Halligan CS, Osmon DR et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 59(12), 1713-1720 (2008).
52. Greenberg JD, Reed GF, Kremer JM et al. Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann. Rheum. Dis. 69(2), 380-386 (2010).
53. Curtis JR, Martin CF, Saag KG et al. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and diseasemodifying antirheumatic drugs. Arthritis Rheum. 57(2), 343-346 (2007).
54. Giles JT, Bartlett SJ, Gelber AC et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum. 55(2), 333-337 (2006).
55. den Broeder AA, Creemers MC, Fransen JF et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J. Rheumatol. 34(4), 689-695 (2007).
56. Ruyssen-Witrand A, Gossec LF et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin. Exp. Rheumatol. 25(3), 430-436 (2007).
57. Johnson BK, Goodman SM, Alexiades MM, Figgie MP, Demmer RT, Mandl LA. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J. Rheumatol. 40(5), 617-623 (2013).
58. Hospital-acquired infections, New York State, 2012. New York State Department of Health (2013). www.health.ny.gov/statistics/facilities/hospital/hospital-acquired-infections/2012/docs/hospital-acquired-infection.pdf
59. Caplan L, Wolfe FF, Russell AS, Michaud K. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J. Rheumatol. 34(4), 696-705 (2007).
60. Dixon WG, Abrahamowicz MF, Beauchamp ME et al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann. Rheum. Dis. 71(7), 1128-1133 (2012).
61. Au K, Reed GF, Curtis JR et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann. Rheum. Dis. 70(5), 785-791 (2011).
62. Ravi B, Croxford RF, Hollands S et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol. 66(2), 254-263 (2014).
63. Nikolaisen C, Figenschau YF, Nossent JC. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J. Rheumatol. 35(3), 380-386 (2008).
64. Del Pozo JL, Patel R. Clinical practice, infection associated with prosthetic joints. N. Engl. J. Med. 361(8), 787-794 (2009).
65. Klareskog L, Padyukov LF, Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Curr. Opin. Rheumatol. 19(1), 49-54 (2007).
66. Turan A, Mascha EJ, Roberman DF et al. Smoking and perioperative outcomes. Anesthesiology 114(4), 837-846 (2011).
67. Hawn MT, Houston TK, Campagna EJ et al. The attributable risk of smoking on surgical complications. Ann. Surg. 254(6), 914-920 (2011).
68. Singh JA. Smoking and outcomes after knee and hip arthroplasty: a systematic review. J. Rheumatol. 38(9), 1824-1834 (2011).
69. Scher JU, Ubeda CF, Equinda MF et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 64(10), 3083-3094 (2012).
70. Smit MD, Westra JF, Vissink AF, Doornbos-van der Meer BF, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res. Ther. 14(5), R222 (2012).
71. Berbari EF, Osmon DR, Duffy MC et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin. Infect. Dis. 142(2), 216-223 (2006).
72. Lavernia CJ, Guzman JF. Relationship of surgical volume to short-term mortality, morbidity, and hospital charges in arthroplasty. J. Arthroplasty 10(2), 133-140 (1995).
73. Losina E, Barrett J, Mahomed NN, Baron JA, Katz JN. Early failures of total hip replacement: effect of surgeon volume. Arthritis Rheum. 50(4), 1338-1343 (2004).
74. Katz JN, Phillips CB, Baron JA et al. Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis Rheum. 48(2), 560-568 (2003).
75. Gravallese EM. Bone destruction in arthritis. Ann. Rheum. Dis. 61(Suppl. 2), ii84-ii86 (2002).
76. Dunbar RP, Alexiades MM. Decision making in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 24(1), 35-54 (1998).
77. Leslie BM. Rheumatoid extensor tendon ruptures. Hand Clin. 5(2), 191-202 (1989).
78. Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J. Hand Surg. Am. 33(1), 49-58 (2008).
79. Jain A, Nanchahal JF, Troeberg LF, Green PF, Brennan F. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. Arthritis Rheum. 44(8), 1754-1760 (2001).
80. Hart DA, Kydd AS, Frank CB, Hildebrand KA. Tissue repair in rheumatoid arthritis: challenges and opportunities in the face of a systemic inflammatory disease. Best Pract. Res. Clin. Rheumatol. 18(2), 187-202 (2004).
81. McGonagle D, Wakefield RJ, Tan AL et al. Distinct topography of erosion and new bone formation in achilles tendon enthesitis: implications for understanding the link between inflammation and bone formation in spondylarthritis. Arthritis Rheum. 58(9), 2694-2699 (2008).
82. Benjamin M, Toumi HF, Ralphs JR, Bydder GF, Best TM, Milz S. Where tendons and ligaments meet bone: attachment sites ('entheses') in relation to exercise and/or mechanical load. J. Anat. 208(4), 471-490 (2006).
83. Gough A, Sambrook PF, Devlin JF et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J. Rheumatol. 25(7), 1282-1289 (1998).
84. Mikuls TR, Saag KG, Curtis JF et al. Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data. J. Natl Med. Assoc. 97(8), 1155-1160 (2005).
85. Shimizu S, Shiozawa S, Shiozawa KF, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum. 28(1), 25-31 (1985).
86. Hastings DE, Parker SM. Protrusio acetabuli in rheumatoid arthritis. Clin. Orthop. Relat. Res. 108, 76-83 (1975).
87. Mibe J, Imakiire AF, Watanabe TF, Fujie T. Results of total hip arthroplasty with bone graft and support ring for protrusio acetabuli in rheumatoid arthritis. J. Orthop. Sci. 10(1), 8-14 (2005).
88. Goldring SR. Periarticular bone changes in rheumatoid arthritis: pathophysiological implications and clinical utility. Ann. Rheum. Dis. 68(3), 297-299 (2009).
89. Green MJ, Deodhar AA. Bone changes in early rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 15(1), 105-123 (2001).
90. Samanta R, Shoukrey KF, Griffiths R. Rheumatoid arthritis and anaesthesia. Anaesthesia 66(12), 1146-1159 (2011).
91. Peltomaa R, Paimela LF, Kautiainen HF, Leirisalo-Repo M. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann. Rheum. Dis. 61(10), 889-894 (2002).
92. Radovits BJ, Fransen JF, Al Shamma S, Eijsbouts AM, van Riel PL, Laan RF. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res. (Hoboken) 62(3), 362-370 (2010).
93. Goodman SM, Figgie M.. Lower extremity arthroplasty in patients with inflammatory arthritis: preoperative and perioperative management. J. Am. Acad. Orth. Surg. 21(6), 355-363 (2013).
94. Osnes-Ringen H, Kvien TK, Henriksen JE, Mowinckel PF, Dagfinrud H. Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life. Ann. Rheum. Dis. 68(10), 1596-1601 (2009).
95. Singh JA, Lewallen DG. Better functional and similar pain outcomes in osteoarthritis compared with rheumatoid arthritis after primary total knee arthroplasty: a cohort study. Arthritis Care Res. (Hoboken) 65(12), 1936-1941 (2013).
96. Singh JA, Lewallen DG. Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared with rheumatoid arthritis after primary hip arthroplasty: a cohort study. BMC Med. 24(11), 210 (2013).
97. Hawker GA, Badley EM, Borkhoff CM et al. Which patients are most likely to benefit from total joint arthroplasty? Arthritis Rheum. 65(5), 1243-1252 (2013).
98. Goodman SM, Johnson B, Huang W, Figgie MP, Alexiades M, Mandl LA. Rheumatoid arthritis patients have similar excellent outcomes after total knee repalcement compared with osteoarthritis patients. Ann. Rheum. Dis. 72(Suppl. 3), 586 (2013).
99. Benoni AC, Bremander AF, Nilsdotter A. Patient-reported outcome after rheumatoid arthritis-related surgery in the lower extremities: a report from the Swedish National Register of Rheuma Surgery (RAKIR). Acta Orthop. 83(2), 179-184 (2012).
100. Goodman SM, Ramsden-Stein DN, Huang WT et al. Patients with rheumatoid arthritis are more likely to have pain and poor function after total hip replacements than patients with osteoarthritis. J. Rheumatol. 41(9), 1774-1780 (2014).
101. Fortin PR, Clarke AE, Joseph L et al. Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum. 42(8), 1722-1728 (1999).
102. Singh JA, Lewallen DG. Ipsilateral lower extremity joint involvement increases the risk of poor pain and function outcomes after hip or knee arthroplasty. BMC Med. 5(11), 144 (2013).
103. Perruccio AV, Power JD, Evans HM et al. Multiple joint involvement in total knee replacement for osteoarthritis: effects on patient-reported outcomes. Arthritis Care Res. (Hoboken) 64(6), 838-846 (2012).
104. Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin. Rheumatol. 28(12), 1419-1430 (2009).
105. Judge A, Javaid MK, Arden NK et al. Clinical tool to identify patients who are most likely to achieve long-term improvement in physical function after total hip arthroplasty. Arthritis Care Res. (Hoboken) 64(6), 881-889 (2012).
106. Gandhi R, Davey JR, Mahomed N. Patient expectations predict greater pain relief with joint arthroplasty. J. Arthroplasty 24(5), 716-721 (2009).
107. Lieberman JR, Thomas BJ, Finerman GA, Dorey F. Patients' reasons for undergoing total hip arthroplasty can change over time. J. Arthroplasty 18(1), 63-68 (2003).
108. Gandhi R, Davey JR, Mahomed NN. Predicting patient dissatisfaction following joint replacement surgery. J. Rheumatol. 35(12), 2415-2418 (2008).
109. Yoo JH, Chang CB, Kang YG, Kim SJ, Seong SC, Kim TK. Patient expectations of total knee replacement and their association with sociodemographic factors and functional status. J. Bone Joint Surg. Br. 93(3), 337-344 (2011).
110. Goodman SM, Mandl LA, Figgie M, Johnson BK, Alexiades M, Ghomrawi H. The use of biologic DMARDs identifies rheumatoid arthritis patients with more optimistic expectations of total knee arthroplasty. HSS J. 10(2), 117-123 (2014).
111. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. Community Hypertension and Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann. Rheum. Dis. 63(4), 395-401 (2004).
112. Lajas C, Abasolo L, Bellajdel B et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum. 49(1), 64-70 (2003).
113. Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 275(11), 858-865 (1996).
114. March LM, Barcenilla AL, Cross MJ, Lapsley HM, Parker DF, Brooks PM. Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis. Clin. Rheumatol. 27(10), 1235-1242 (2008).
115. Hawker GA, Badley EM, Croxford R et al. A population based nested case-control study of the costs of hip and knee replacement surgery. Med. Care 47(7), 732-741 (2009).